Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2016

Open Access 01-12-2016 | Research

POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification

Authors: Nobuyuki Araki, Sonoko Misawa, Kazumoto Shibuya, Satoshi Ota, Takashi Oide, Asuka Kawano, Minako Beppu, Yukio Nakatani, Satoshi Kuwabara

Published in: Orphanet Journal of Rare Diseases | Issue 1/2016

Login to get access

Abstract

Background

Calciphylaxis is a syndrome consisting of vascular calcification, thrombosis, and skin necrosis. The syndrome develops often in chronic hemodialysis patients. However, there have been several case reports on calciphylaxis in patients with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome, a systemic disease associated with plasma cell dyscrasia and upregulation of vascular endothelial growth factor (VEGF).

Methods

In 76 POEMS patients and 86 age- and gender-matched disease controls, we studied abnormal small vessel calcification by computed tomography (CT) of the soft tissues. Clinical and laboratory profiles were compared between POEMS patients with and without calciphylaxis. Histological examination was performed in six autopsy cases.

Results

Small vessel calcification on CT was found in 17 % of POEMS patients and in none of the controls (P < 0.001). Autopsy confirmed calciphylaxis in 2 (33 %) patients. Among POEMS patients, higher disease activity, including more severe neuropathy and ascites, higher serum levels of interleukin-6, and lower serum albumin levels, was associated with the development of calciphylaxis. Serum levels of creatinine, calcium, and phosphate were not related to the presence of calciphylaxis.

Conclusions

Calciphylaxis is often present in patients with POEMS syndrome. Upregulation of multiple inflammatory cytokines such as VEGF and interleukin-6 may contribute to the development of calciphylaxis, by entirely different mechanism from that in chronic dialysis. POEMS syndrome should be recognized as a potential cause of calciphylaxis.
Literature
1.
go back to reference Arseculeratne G, Evans AT, Morley SM. Calciphylaxis--a topical overview. J Eur Acad Dermatol Venereol. 2006;20(5):493–502.CrossRefPubMed Arseculeratne G, Evans AT, Morley SM. Calciphylaxis--a topical overview. J Eur Acad Dermatol Venereol. 2006;20(5):493–502.CrossRefPubMed
2.
go back to reference Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56(4):569–79.CrossRefPubMed Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56(4):569–79.CrossRefPubMed
3.
go back to reference Weenig RH. Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol. 2008;58(3):458–71.CrossRefPubMed Weenig RH. Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol. 2008;58(3):458–71.CrossRefPubMed
4.
go back to reference Yerram P, Chaudhary K. Calcific uremic arteriolopathy in end stage renal disease: pathophysiology and management. Ochsner J. 2014;14(3):380–5.PubMedPubMedCentral Yerram P, Chaudhary K. Calcific uremic arteriolopathy in end stage renal disease: pathophysiology and management. Ochsner J. 2014;14(3):380–5.PubMedPubMedCentral
5.
go back to reference Dominguez AR, Goldman SE. Nonuremic calciphylaxis in a patient with rheumatoid arthritis and osteoporosis treated with teriparatide. J Am Acad Dermatol. 2014;70(2):e41–2.CrossRefPubMed Dominguez AR, Goldman SE. Nonuremic calciphylaxis in a patient with rheumatoid arthritis and osteoporosis treated with teriparatide. J Am Acad Dermatol. 2014;70(2):e41–2.CrossRefPubMed
6.
go back to reference Breakey W, Hall C, Vann Jones S, Husain A, Kernohan M. Warfarin-induced skin necrosis progressing to calciphylaxis. J Plast Reconstr Aesthet Surg. 2014;67(10):e244–6.CrossRefPubMed Breakey W, Hall C, Vann Jones S, Husain A, Kernohan M. Warfarin-induced skin necrosis progressing to calciphylaxis. J Plast Reconstr Aesthet Surg. 2014;67(10):e244–6.CrossRefPubMed
7.
go back to reference Sermijn E, Strobbe T, Vandekerckhove L, Libbrecht L, Colle I, Schoonjans R, Vogelaers D. Calciphylaxis: a rare complication in alcoholic liver disease. Acta Clin Belg. 2013;68(2):116–9.CrossRefPubMed Sermijn E, Strobbe T, Vandekerckhove L, Libbrecht L, Colle I, Schoonjans R, Vogelaers D. Calciphylaxis: a rare complication in alcoholic liver disease. Acta Clin Belg. 2013;68(2):116–9.CrossRefPubMed
8.
go back to reference Ferreres JR, Marcoval J, Bordas X, Moreno A, Muniesa C, Prat C, Peyri J. Calciphylaxis associated with alcoholic cirrhosis. J Eur Acad Dermatol Venereol. 2006;20(5):599–601.CrossRefPubMed Ferreres JR, Marcoval J, Bordas X, Moreno A, Muniesa C, Prat C, Peyri J. Calciphylaxis associated with alcoholic cirrhosis. J Eur Acad Dermatol Venereol. 2006;20(5):599–601.CrossRefPubMed
9.
go back to reference Ozbalkan Z, Calguneri M, Onat AM, Ozturk MA. Development of calciphylaxis after long-term steroid and methotroxate use in a patient with rheumatoid arthritis. IntMed (Tokyo, Japan). 2005;44(11):1178–81.CrossRef Ozbalkan Z, Calguneri M, Onat AM, Ozturk MA. Development of calciphylaxis after long-term steroid and methotroxate use in a patient with rheumatoid arthritis. IntMed (Tokyo, Japan). 2005;44(11):1178–81.CrossRef
10.
go back to reference Korkmaz C, Dundar E, Zubaroglu I. Calciphylaxis in a patient with rheumatoid arthritis without renal failure and hyperparathyroidism: the possible role of long-term steroid use and protein S deficiency. Clin Rheumatol. 2002;21(1):66–9.CrossRefPubMed Korkmaz C, Dundar E, Zubaroglu I. Calciphylaxis in a patient with rheumatoid arthritis without renal failure and hyperparathyroidism: the possible role of long-term steroid use and protein S deficiency. Clin Rheumatol. 2002;21(1):66–9.CrossRefPubMed
11.
go back to reference Salmhofer H, Franzen M, Hitzl W, Koller J, Kreymann B, Fend F, Hauser-Kronberger C, Heemann U, Berr F, Schmaderer C. Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data. Kidney Blood Press Res. 2013;37(4-5):346–59.CrossRefPubMed Salmhofer H, Franzen M, Hitzl W, Koller J, Kreymann B, Fend F, Hauser-Kronberger C, Heemann U, Berr F, Schmaderer C. Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data. Kidney Blood Press Res. 2013;37(4-5):346–59.CrossRefPubMed
12.
go back to reference Ning MS, Dahir KM, Castellanos EH, McGirt LY. Sodium thiosulfate in the treatment of non-uremic calciphylaxis. J Dermatol. 2013;40(8):649–52.CrossRefPubMed Ning MS, Dahir KM, Castellanos EH, McGirt LY. Sodium thiosulfate in the treatment of non-uremic calciphylaxis. J Dermatol. 2013;40(8):649–52.CrossRefPubMed
13.
go back to reference Kuwabara S, Dispenzieri A, Arimura K, Misawa S, Nakaseko C. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Cochrane DatabaseSyst Rev. 2012;6:Cd006828. Kuwabara S, Dispenzieri A, Arimura K, Misawa S, Nakaseko C. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Cochrane DatabaseSyst Rev. 2012;6:Cd006828.
14.
go back to reference Dispenzieri A. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014;89(2):214–23.CrossRefPubMed Dispenzieri A. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014;89(2):214–23.CrossRefPubMed
15.
go back to reference De Roma I, Filotico R, Cea M, Procaccio P, Perosa F. Calciphylaxis in a patient with POEMS syndrome without renal failure and/or hyperparathyroidism. A case report. Ann Ital Med Int. 2004;19(4):283–7.PubMed De Roma I, Filotico R, Cea M, Procaccio P, Perosa F. Calciphylaxis in a patient with POEMS syndrome without renal failure and/or hyperparathyroidism. A case report. Ann Ital Med Int. 2004;19(4):283–7.PubMed
16.
go back to reference Hineno A, Kinoshita T, Kinoshita M, Arakura F, Naito KS, Shimojima Y, Matsuda M, Yoshida K, Ikeda SI. Calciphylaxis as a Catastrophic Complication in a Patient with POEMS Syndrome. Case Rep Neurol. 2009;1(1):47–53.CrossRefPubMedPubMedCentral Hineno A, Kinoshita T, Kinoshita M, Arakura F, Naito KS, Shimojima Y, Matsuda M, Yoshida K, Ikeda SI. Calciphylaxis as a Catastrophic Complication in a Patient with POEMS Syndrome. Case Rep Neurol. 2009;1(1):47–53.CrossRefPubMedPubMedCentral
17.
go back to reference Lee FY, Chiu HC. POEMS syndrome with calciphylaxis: A case report. Acta Derm Venereol. 2011;91(1):96–7.CrossRefPubMed Lee FY, Chiu HC. POEMS syndrome with calciphylaxis: A case report. Acta Derm Venereol. 2011;91(1):96–7.CrossRefPubMed
18.
go back to reference Heck D, Mergen M, Ganner A, Pelisek J, Mader I, Weiller C, Niesen WD. POEMS syndrome, calciphylaxis and focal segmental glomerulosclerosis inverted question mark VEGF as a possible link. BMC Neurol. 2014;14(1):210.CrossRefPubMedPubMedCentral Heck D, Mergen M, Ganner A, Pelisek J, Mader I, Weiller C, Niesen WD. POEMS syndrome, calciphylaxis and focal segmental glomerulosclerosis inverted question mark VEGF as a possible link. BMC Neurol. 2014;14(1):210.CrossRefPubMedPubMedCentral
19.
go back to reference Novoa RA, Honda KS, Campagnaro E, Gerstenblith MR. Hypertensive emergency, matlike telangiectasias, and calciphylaxis in POEMS syndrome. JAMA Dermatol. 2014;150(6):667–9.CrossRefPubMed Novoa RA, Honda KS, Campagnaro E, Gerstenblith MR. Hypertensive emergency, matlike telangiectasias, and calciphylaxis in POEMS syndrome. JAMA Dermatol. 2014;150(6):667–9.CrossRefPubMed
21.
go back to reference Shmidt E, Murthy NS, Knudsen JM, Weenig RH, Jacobs MA, Starnes AM, Davis MD. Net-like pattern of calcification on plain soft-tissue radiographs in patients with calciphylaxis. J Am Acad Dermatol. 2012;67(6):1296–301.CrossRefPubMed Shmidt E, Murthy NS, Knudsen JM, Weenig RH, Jacobs MA, Starnes AM, Davis MD. Net-like pattern of calcification on plain soft-tissue radiographs in patients with calciphylaxis. J Am Acad Dermatol. 2012;67(6):1296–301.CrossRefPubMed
22.
23.
go back to reference London GM. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731–40.CrossRefPubMed London GM. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731–40.CrossRefPubMed
24.
25.
go back to reference Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16(8):978–83.CrossRefPubMed Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16(8):978–83.CrossRefPubMed
26.
27.
go back to reference Kanai K, Sawai S, Sogawa K, Mori M, Misawa S, Shibuya K, Isose S, Fujimaki Y, Noto Y, Sekiguchi Y et al. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome. Neurology. 2012;79(6):575–82.CrossRefPubMed Kanai K, Sawai S, Sogawa K, Mori M, Misawa S, Shibuya K, Isose S, Fujimaki Y, Noto Y, Sekiguchi Y et al. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome. Neurology. 2012;79(6):575–82.CrossRefPubMed
28.
go back to reference Tokashiki T, Hashiguchi T, Arimura K, Eiraku N, Maruyama I, Osame M. Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome. Int Med (Tokyo, Japan). 2003;42(12):1240–3.CrossRef Tokashiki T, Hashiguchi T, Arimura K, Eiraku N, Maruyama I, Osame M. Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome. Int Med (Tokyo, Japan). 2003;42(12):1240–3.CrossRef
29.
go back to reference Deuell KA, Callegari A, Giachelli CM, Rosenfeld ME, Scatena M. RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-alpha. J Vasc Res. 2012;49(6):510–21.CrossRefPubMedPubMedCentral Deuell KA, Callegari A, Giachelli CM, Rosenfeld ME, Scatena M. RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-alpha. J Vasc Res. 2012;49(6):510–21.CrossRefPubMedPubMedCentral
Metadata
Title
POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification
Authors
Nobuyuki Araki
Sonoko Misawa
Kazumoto Shibuya
Satoshi Ota
Takashi Oide
Asuka Kawano
Minako Beppu
Yukio Nakatani
Satoshi Kuwabara
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2016
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-016-0421-3

Other articles of this Issue 1/2016

Orphanet Journal of Rare Diseases 1/2016 Go to the issue